Clinical Trial Update: Apatinib Plus SHR1210 in Advanced Mucosal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib plus SHR1210 in advanced mucosal melanoma; currently status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Apatinib (apatinib)
• SHR1210 (SHR-1210)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Mucosal Melanoma, Advanced Cancer | Phase 2 | Status: UNKNOWN